Product Introduction
Bioactivity


英文名: Hydroxychloroquine sulfate

描述: Hydroxychloroquine sulfate (Acidum iopanoicum) 抑制疟原虫血红素聚合酶。它还可抑制 Toll 样受体 7/9 信号传导和 SARS-CoV-2 感染。

细胞实验: All cells are cultured in RPMI with 10% FBS, 1% glutamine, and 1% Pen/Strep. cells are seeded on the appropriated plates overnight and treated with HCQ (75 or 100 μM) for 48 hours.(Only for Reference)

激酶实验: In vitro kinase assays: with purified proteins, recombinant S6 protein and recombinant active P70S6K are incubated in 1x kinase buffer with various amount of HCQ or RAD001 in the presence (25 μM) or absence of ATP for 30 minutes at 30°C. Total and phosphorylated S6 at ser235/236 and ser240/244 are detected by western analysis using phosphospecific antibodies. Note that recombinant GST-tagged S6 (53 kd) is distinguished from endogenous S6 (32 kd) on the western blot.

体外活性: Hydroxychloroquine sulfate 是一种有效的自噬抑制剂。Hydroxychloroquine sulfate 通过阻止溶酶体酸化从而干扰自噬过程中的关键步骤。HCQ治疗抑制RCC（肾细胞癌）细胞增殖，促进细胞凋亡，抑制线粒体氧气消耗，并提高糖酵解速率[2]。

体内活性: Hydroxychloroquine Sulfate 在大鼠I/R损伤模型中减少梗死面积，其心脏保护作用依赖于ERK1/2[3]。此外，Hydroxychloroquine Sulfate展现出早期的血管保护效应。HCQ似乎能预防接受治疗的动物出现内皮功能障碍(ED)[4]。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : Insoluble
H2O : 10 mM


关键字: HCQ | Inhibitor | Toll-like Receptor (TLR) | SARS-CoV | Autophagy | SARS coronavirus | Hydroxychloroquine | Hydroxychloroquine sulfate | inhibit | Hydroxychloroquine Sulfate | Parasite | HCQ Sulfate

相关产品: Chromium picolinate | Norharmane | 4-Ethylcatechol | BTB09089 | Gemcitabine monophosphate sodium salt hydrate | L189 | Crystal Violet | 3,7,4'-Trihydroxyflavone | G150 | BCL6-IN-3

相关库: Drug Repurposing Compound Library | Pyroptosis Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Immuno-Oncology Compound Library | Membrane Protein-targeted Compound Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Anti-Parasitic Compound Library | Anti-Cancer Approved Drug Library